Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Neoplasms | 63 | 2024 | 1420 | 11.510 |
Why?
|
Endometrial Neoplasms | 78 | 2023 | 1366 | 9.580 |
Why?
|
Endometrial Stromal Tumors | 18 | 2023 | 46 | 7.780 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 26 | 2024 | 118 | 6.850 |
Why?
|
Sarcoma, Endometrial Stromal | 25 | 2023 | 93 | 6.570 |
Why?
|
Carcinoma, Endometrioid | 33 | 2023 | 276 | 6.060 |
Why?
|
Ovarian Neoplasms | 80 | 2024 | 4878 | 5.520 |
Why?
|
Uterine Cervical Neoplasms | 45 | 2024 | 2020 | 4.730 |
Why?
|
Genital Neoplasms, Female | 16 | 2022 | 532 | 4.070 |
Why?
|
Immunohistochemistry | 100 | 2024 | 11076 | 3.170 |
Why?
|
Smooth Muscle Tumor | 12 | 2021 | 63 | 3.110 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 7 | 2023 | 77 | 2.800 |
Why?
|
Carcinoma | 24 | 2022 | 2330 | 2.470 |
Why?
|
Leiomyoma | 12 | 2024 | 636 | 2.450 |
Why?
|
Adenocarcinoma | 39 | 2024 | 6345 | 2.370 |
Why?
|
Leiomyosarcoma | 16 | 2023 | 422 | 2.220 |
Why?
|
Adenocarcinoma, Clear Cell | 15 | 2022 | 217 | 2.210 |
Why?
|
In Situ Hybridization, Fluorescence | 29 | 2024 | 2510 | 2.070 |
Why?
|
Adenosarcoma | 5 | 2022 | 36 | 1.980 |
Why?
|
Pathology | 8 | 2024 | 270 | 1.980 |
Why?
|
Diagnosis, Differential | 74 | 2024 | 12973 | 1.950 |
Why?
|
Gynecology | 18 | 2024 | 526 | 1.830 |
Why?
|
Carcinosarcoma | 9 | 2019 | 106 | 1.780 |
Why?
|
Uterus | 15 | 2023 | 649 | 1.700 |
Why?
|
Vulvar Neoplasms | 8 | 2022 | 263 | 1.620 |
Why?
|
Rhabdomyosarcoma, Embryonal | 3 | 2022 | 100 | 1.540 |
Why?
|
Gene Rearrangement | 16 | 2020 | 1125 | 1.510 |
Why?
|
Female | 333 | 2024 | 392705 | 1.460 |
Why?
|
Papillomavirus Infections | 18 | 2024 | 1613 | 1.390 |
Why?
|
Gene Fusion | 12 | 2022 | 356 | 1.380 |
Why?
|
Endometrium | 12 | 2023 | 403 | 1.350 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 10 | 2024 | 698 | 1.350 |
Why?
|
14-3-3 Proteins | 6 | 2023 | 220 | 1.320 |
Why?
|
Neoplasm Staging | 55 | 2024 | 11120 | 1.300 |
Why?
|
Myofibroma | 2 | 2020 | 45 | 1.280 |
Why?
|
Myelodysplastic Syndromes | 12 | 2023 | 1394 | 1.260 |
Why?
|
Hysterectomy | 15 | 2022 | 857 | 1.260 |
Why?
|
Cystadenocarcinoma, Serous | 11 | 2022 | 478 | 1.260 |
Why?
|
Adenocarcinoma, Mucinous | 6 | 2020 | 517 | 1.250 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 5 | 2018 | 380 | 1.220 |
Why?
|
DNA Mismatch Repair | 5 | 2022 | 428 | 1.140 |
Why?
|
Testicular Neoplasms | 8 | 2024 | 799 | 1.110 |
Why?
|
Ribonuclease III | 5 | 2022 | 279 | 1.100 |
Why?
|
Adnexal Diseases | 3 | 2019 | 104 | 1.090 |
Why?
|
Azacitidine | 4 | 2024 | 336 | 1.050 |
Why?
|
Humans | 360 | 2024 | 761596 | 1.040 |
Why?
|
DEAD-box RNA Helicases | 5 | 2022 | 384 | 1.030 |
Why?
|
Cysts | 4 | 2024 | 681 | 1.030 |
Why?
|
Carcinoma, Small Cell | 6 | 2022 | 420 | 1.010 |
Why?
|
Papillomaviridae | 15 | 2023 | 1119 | 1.010 |
Why?
|
Granulosa Cell Tumor | 9 | 2024 | 77 | 1.010 |
Why?
|
Carcinoma, Adenosquamous | 4 | 2022 | 66 | 1.000 |
Why?
|
Chromosomes, Human, Pair 5 | 3 | 2018 | 386 | 0.980 |
Why?
|
MutS Homolog 2 Protein | 4 | 2019 | 197 | 0.970 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 4 | 2021 | 318 | 0.940 |
Why?
|
Middle Aged | 171 | 2024 | 220921 | 0.930 |
Why?
|
Pregnancy Complications, Neoplastic | 6 | 2020 | 258 | 0.930 |
Why?
|
DNA-Binding Proteins | 25 | 2024 | 9610 | 0.920 |
Why?
|
Neoplasms, Adnexal and Skin Appendage | 2 | 2022 | 27 | 0.920 |
Why?
|
Adenoma | 5 | 2022 | 2163 | 0.910 |
Why?
|
Prognosis | 58 | 2024 | 29629 | 0.890 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 6 | 2022 | 491 | 0.890 |
Why?
|
Mixed Tumor, Mullerian | 6 | 2017 | 55 | 0.860 |
Why?
|
Neoplasm Proteins | 18 | 2021 | 3617 | 0.850 |
Why?
|
Broad Ligament | 1 | 2022 | 5 | 0.830 |
Why?
|
Genitalia, Female | 3 | 2020 | 147 | 0.820 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2022 | 30 | 0.810 |
Why?
|
Adult | 150 | 2024 | 221210 | 0.800 |
Why?
|
Aged | 136 | 2024 | 169310 | 0.800 |
Why?
|
Teratoma | 4 | 2022 | 404 | 0.800 |
Why?
|
Neoplasms, Muscle Tissue | 2 | 2024 | 67 | 0.790 |
Why?
|
Chromosome Deletion | 3 | 2018 | 1386 | 0.770 |
Why?
|
Choristoma | 1 | 2023 | 206 | 0.770 |
Why?
|
Transcription Factors | 20 | 2021 | 12130 | 0.760 |
Why?
|
Adenomatoid Tumor | 1 | 2021 | 12 | 0.760 |
Why?
|
Cervix Uteri | 11 | 2023 | 570 | 0.750 |
Why?
|
Hypercalcemia | 6 | 2019 | 423 | 0.750 |
Why?
|
Solitary Fibrous Tumors | 1 | 2022 | 67 | 0.750 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2020 | 40 | 0.740 |
Why?
|
Carcinoma, Transitional Cell | 9 | 2012 | 783 | 0.730 |
Why?
|
Thalidomide | 3 | 2016 | 885 | 0.730 |
Why?
|
Germinoma | 4 | 2022 | 132 | 0.700 |
Why?
|
Sarcoma | 9 | 2023 | 1801 | 0.690 |
Why?
|
Adnexa Uteri | 1 | 2019 | 40 | 0.680 |
Why?
|
Androgen-Insensitivity Syndrome | 2 | 2018 | 33 | 0.680 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2022 | 245 | 0.680 |
Why?
|
Carcinoma, Squamous Cell | 11 | 2024 | 4024 | 0.670 |
Why?
|
Remission Induction | 2 | 2024 | 2397 | 0.650 |
Why?
|
Necrosis | 8 | 2022 | 1611 | 0.640 |
Why?
|
Societies, Medical | 17 | 2021 | 3905 | 0.640 |
Why?
|
Co-Repressor Proteins | 6 | 2023 | 190 | 0.640 |
Why?
|
Isochromosomes | 1 | 2018 | 16 | 0.640 |
Why?
|
Precancerous Conditions | 6 | 2021 | 980 | 0.640 |
Why?
|
Fumarate Hydratase | 2 | 2024 | 52 | 0.620 |
Why?
|
Placenta | 4 | 2020 | 1709 | 0.620 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2022 | 339 | 0.620 |
Why?
|
Epithelioid Cells | 1 | 2018 | 60 | 0.620 |
Why?
|
Neprilysin | 6 | 2007 | 478 | 0.620 |
Why?
|
Ovarian Diseases | 3 | 2015 | 137 | 0.610 |
Why?
|
Genital Diseases, Female | 3 | 2015 | 192 | 0.610 |
Why?
|
Aged, 80 and over | 67 | 2024 | 58984 | 0.610 |
Why?
|
Carcinoma, Papillary | 4 | 2015 | 785 | 0.610 |
Why?
|
Kidney Neoplasms | 9 | 2021 | 4251 | 0.600 |
Why?
|
Tissue Array Analysis | 13 | 2021 | 550 | 0.590 |
Why?
|
DNA Repair Enzymes | 2 | 2018 | 346 | 0.590 |
Why?
|
Nuclear Proteins | 10 | 2021 | 5799 | 0.590 |
Why?
|
Mutation | 29 | 2024 | 30053 | 0.580 |
Why?
|
Fibronectins | 1 | 2021 | 723 | 0.580 |
Why?
|
beta Catenin | 10 | 2023 | 1040 | 0.580 |
Why?
|
Tumor Suppressor Protein p53 | 13 | 2023 | 2917 | 0.580 |
Why?
|
Neoplasms, Glandular and Epithelial | 3 | 2013 | 487 | 0.570 |
Why?
|
Urethral Neoplasms | 6 | 2010 | 37 | 0.570 |
Why?
|
Paraneoplastic Syndromes | 1 | 2019 | 155 | 0.570 |
Why?
|
Pancreas | 2 | 2023 | 1691 | 0.570 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2019 | 610 | 0.570 |
Why?
|
Mesothelioma | 2 | 2022 | 807 | 0.570 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2017 | 43 | 0.560 |
Why?
|
Urinary Bladder Neoplasms | 10 | 2014 | 2223 | 0.560 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2018 | 430 | 0.560 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 6 | 2020 | 194 | 0.550 |
Why?
|
Proto-Oncogene Proteins | 6 | 2021 | 4514 | 0.550 |
Why?
|
Peritoneal Neoplasms | 2 | 2022 | 711 | 0.550 |
Why?
|
Carcinoma, Renal Cell | 6 | 2021 | 3165 | 0.530 |
Why?
|
Neoplasm Invasiveness | 23 | 2023 | 3597 | 0.530 |
Why?
|
Neuroendocrine Tumors | 1 | 2022 | 641 | 0.520 |
Why?
|
Carcinoma in Situ | 5 | 2021 | 791 | 0.510 |
Why?
|
WT1 Proteins | 3 | 2015 | 184 | 0.510 |
Why?
|
Predictive Value of Tests | 27 | 2024 | 15266 | 0.500 |
Why?
|
Fallopian Tube Neoplasms | 6 | 2015 | 328 | 0.500 |
Why?
|
Giant Cell Tumors | 1 | 2015 | 89 | 0.490 |
Why?
|
Cell Nucleus Shape | 1 | 2014 | 16 | 0.490 |
Why?
|
Repressor Proteins | 7 | 2023 | 2986 | 0.490 |
Why?
|
Osteosarcoma | 2 | 2018 | 897 | 0.490 |
Why?
|
Myometrium | 6 | 2021 | 174 | 0.470 |
Why?
|
Lymph Nodes | 10 | 2022 | 3465 | 0.470 |
Why?
|
Practice Guidelines as Topic | 15 | 2021 | 7391 | 0.470 |
Why?
|
Stromal Cells | 10 | 2020 | 1330 | 0.460 |
Why?
|
Cyclin D1 | 7 | 2023 | 451 | 0.460 |
Why?
|
Muscle, Smooth | 4 | 2014 | 926 | 0.450 |
Why?
|
Kaplan-Meier Estimate | 13 | 2021 | 6484 | 0.450 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2023 | 1609 | 0.450 |
Why?
|
Adenosine Triphosphatases | 3 | 2016 | 836 | 0.450 |
Why?
|
Leukemia, Myeloid | 3 | 2011 | 694 | 0.450 |
Why?
|
Leukemia, Myeloid, Acute | 7 | 2024 | 3615 | 0.450 |
Why?
|
Neoplasm Recurrence, Local | 18 | 2024 | 9280 | 0.440 |
Why?
|
Proto-Oncogene Proteins c-kit | 4 | 2013 | 727 | 0.440 |
Why?
|
Ovary | 7 | 2021 | 959 | 0.440 |
Why?
|
Biopsy | 14 | 2022 | 6766 | 0.430 |
Why?
|
Lymphatic Metastasis | 11 | 2023 | 2915 | 0.430 |
Why?
|
Angiomyolipoma | 2 | 2013 | 187 | 0.430 |
Why?
|
DNA Helicases | 4 | 2021 | 851 | 0.420 |
Why?
|
DNA Mutational Analysis | 15 | 2022 | 4111 | 0.420 |
Why?
|
Mitosis | 5 | 2023 | 1188 | 0.410 |
Why?
|
Infertility, Female | 1 | 2018 | 760 | 0.410 |
Why?
|
Lipoma | 2 | 2011 | 293 | 0.410 |
Why?
|
Receptors, Progesterone | 6 | 2019 | 1129 | 0.400 |
Why?
|
Neoplasms, Connective and Soft Tissue | 2 | 2023 | 34 | 0.400 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2021 | 2425 | 0.400 |
Why?
|
Mitotic Index | 6 | 2020 | 162 | 0.390 |
Why?
|
Endometrial Hyperplasia | 3 | 2021 | 97 | 0.390 |
Why?
|
Uterine Hemorrhage | 1 | 2013 | 240 | 0.380 |
Why?
|
DNA, Neoplasm | 7 | 2018 | 1745 | 0.370 |
Why?
|
Anti-Mullerian Hormone | 5 | 2023 | 407 | 0.370 |
Why?
|
Forkhead Transcription Factors | 2 | 2015 | 1616 | 0.370 |
Why?
|
Survival Rate | 22 | 2021 | 12723 | 0.370 |
Why?
|
Antimetabolites, Antineoplastic | 4 | 2024 | 646 | 0.370 |
Why?
|
HMGA2 Protein | 2 | 2012 | 102 | 0.360 |
Why?
|
Trophoblastic Neoplasms | 1 | 2010 | 88 | 0.360 |
Why?
|
Angiogenesis Inhibitors | 2 | 2013 | 2048 | 0.360 |
Why?
|
Premenopause | 1 | 2015 | 1039 | 0.360 |
Why?
|
Cell Nucleus | 9 | 2023 | 2910 | 0.360 |
Why?
|
Vaginal Neoplasms | 3 | 2012 | 104 | 0.350 |
Why?
|
Observer Variation | 12 | 2021 | 2606 | 0.350 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2010 | 95 | 0.350 |
Why?
|
Soft Tissue Neoplasms | 3 | 2023 | 1159 | 0.350 |
Why?
|
Iron Overload | 3 | 2017 | 239 | 0.350 |
Why?
|
Mullerian Ducts | 3 | 2019 | 203 | 0.350 |
Why?
|
Choriocarcinoma | 2 | 2004 | 121 | 0.340 |
Why?
|
Erythropoietin | 4 | 2018 | 719 | 0.340 |
Why?
|
Immunologic Factors | 2 | 2016 | 1590 | 0.330 |
Why?
|
Neoplasms, Multiple Primary | 3 | 2011 | 592 | 0.330 |
Why?
|
Wolffian Ducts | 2 | 2022 | 27 | 0.330 |
Why?
|
Stomach Neoplasms | 4 | 2022 | 1459 | 0.320 |
Why?
|
Leiomyomatosis | 4 | 2020 | 69 | 0.310 |
Why?
|
Chromosome Aberrations | 3 | 2024 | 1768 | 0.310 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2012 | 549 | 0.310 |
Why?
|
Alphapapillomavirus | 2 | 2022 | 218 | 0.310 |
Why?
|
Disease-Free Survival | 9 | 2024 | 6815 | 0.310 |
Why?
|
Endometriosis | 4 | 2015 | 870 | 0.300 |
Why?
|
Liposarcoma | 1 | 2011 | 289 | 0.300 |
Why?
|
Boston | 9 | 2021 | 9327 | 0.300 |
Why?
|
Cystadenocarcinoma, Papillary | 2 | 2006 | 56 | 0.290 |
Why?
|
Frozen Sections | 1 | 2008 | 153 | 0.290 |
Why?
|
Rhabdoid Tumor | 2 | 2020 | 210 | 0.290 |
Why?
|
Tumor Burden | 7 | 2024 | 1892 | 0.290 |
Why?
|
Nephroma, Mesoblastic | 1 | 2007 | 24 | 0.290 |
Why?
|
Cell Transformation, Neoplastic | 10 | 2020 | 2827 | 0.280 |
Why?
|
Young Adult | 28 | 2024 | 59260 | 0.280 |
Why?
|
Tuberous Sclerosis | 2 | 2014 | 1030 | 0.280 |
Why?
|
Keratins | 6 | 2010 | 498 | 0.270 |
Why?
|
Neoplasms, Second Primary | 2 | 2012 | 1052 | 0.270 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2016 | 2898 | 0.270 |
Why?
|
Retrospective Studies | 44 | 2024 | 80647 | 0.260 |
Why?
|
Cyclins | 3 | 2007 | 594 | 0.260 |
Why?
|
Nephrectomy | 3 | 2021 | 937 | 0.260 |
Why?
|
Lymph Node Excision | 7 | 2023 | 1271 | 0.260 |
Why?
|
Myxoma | 1 | 2006 | 114 | 0.260 |
Why?
|
Combined Modality Therapy | 14 | 2017 | 8527 | 0.260 |
Why?
|
Postmenopause | 1 | 2015 | 2513 | 0.260 |
Why?
|
Anemia | 2 | 2018 | 1509 | 0.260 |
Why?
|
Receptors, Transforming Growth Factor beta | 4 | 2023 | 302 | 0.250 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2529 | 0.250 |
Why?
|
Adenocarcinoma, Papillary | 2 | 2019 | 84 | 0.250 |
Why?
|
Adolescent | 34 | 2024 | 88326 | 0.250 |
Why?
|
Urologic Neoplasms | 2 | 2006 | 314 | 0.250 |
Why?
|
Fatal Outcome | 4 | 2018 | 1835 | 0.250 |
Why?
|
Telomerase | 2 | 2022 | 745 | 0.240 |
Why?
|
Sertoli Cell Tumor | 1 | 2005 | 36 | 0.240 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2013 | 2865 | 0.230 |
Why?
|
Fallopian Tubes | 3 | 2011 | 178 | 0.230 |
Why?
|
Human papillomavirus 18 | 2 | 2022 | 125 | 0.230 |
Why?
|
Calmodulin-Binding Proteins | 3 | 2017 | 233 | 0.230 |
Why?
|
Terminology as Topic | 5 | 2018 | 1530 | 0.230 |
Why?
|
Endodermal Sinus Tumor | 2 | 2022 | 53 | 0.220 |
Why?
|
Perinatal Care | 1 | 2006 | 244 | 0.220 |
Why?
|
Follow-Up Studies | 16 | 2022 | 39106 | 0.220 |
Why?
|
Hematinics | 3 | 2018 | 282 | 0.220 |
Why?
|
Gonadoblastoma | 2 | 2022 | 14 | 0.220 |
Why?
|
Gene Expression Regulation, Neoplastic | 12 | 2020 | 8554 | 0.220 |
Why?
|
Colonic Neoplasms | 3 | 2018 | 2539 | 0.210 |
Why?
|
Human papillomavirus 16 | 2 | 2022 | 267 | 0.210 |
Why?
|
Education, Distance | 2 | 2024 | 261 | 0.210 |
Why?
|
Retroperitoneal Space | 1 | 2023 | 170 | 0.210 |
Why?
|
Translocation, Genetic | 4 | 2011 | 1393 | 0.210 |
Why?
|
Ovariectomy | 3 | 2017 | 614 | 0.210 |
Why?
|
Papilloma | 1 | 2023 | 140 | 0.210 |
Why?
|
Peptide Hormones | 1 | 2023 | 132 | 0.200 |
Why?
|
Cadherins | 4 | 2016 | 903 | 0.200 |
Why?
|
Abdominal Neoplasms | 2 | 2019 | 287 | 0.200 |
Why?
|
Receptors, Peptide | 3 | 2021 | 279 | 0.200 |
Why?
|
Dioxygenases | 1 | 2024 | 345 | 0.200 |
Why?
|
Germ-Line Mutation | 3 | 2023 | 1858 | 0.200 |
Why?
|
Orchiectomy | 2 | 2022 | 463 | 0.200 |
Why?
|
Treatment Outcome | 21 | 2024 | 64685 | 0.200 |
Why?
|
Pyrroles | 1 | 2008 | 1125 | 0.190 |
Why?
|
Metaplasia | 3 | 2014 | 322 | 0.190 |
Why?
|
Male | 62 | 2024 | 360846 | 0.190 |
Why?
|
Receptor, trkA | 2 | 2023 | 159 | 0.190 |
Why?
|
Glomus Tumor | 1 | 2022 | 62 | 0.190 |
Why?
|
Gastric Mucosa | 2 | 2023 | 604 | 0.190 |
Why?
|
Mesenchymoma | 2 | 2007 | 49 | 0.190 |
Why?
|
Serous Membrane | 1 | 2021 | 24 | 0.190 |
Why?
|
Immunophenotyping | 4 | 2021 | 1869 | 0.190 |
Why?
|
Phenotype | 10 | 2023 | 16592 | 0.190 |
Why?
|
Lung Neoplasms | 3 | 2022 | 13381 | 0.190 |
Why?
|
Claudins | 1 | 2022 | 117 | 0.190 |
Why?
|
Histone Deacetylases | 1 | 2006 | 720 | 0.190 |
Why?
|
Curettage | 1 | 2021 | 74 | 0.190 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2021 | 59 | 0.190 |
Why?
|
Quality of Life | 5 | 2019 | 13367 | 0.190 |
Why?
|
Carrier Proteins | 5 | 2011 | 4937 | 0.180 |
Why?
|
Iron Chelating Agents | 3 | 2017 | 141 | 0.180 |
Why?
|
In Situ Hybridization | 4 | 2018 | 1900 | 0.180 |
Why?
|
Genes, cdc | 1 | 2020 | 114 | 0.180 |
Why?
|
Oncogene Fusion | 1 | 2020 | 81 | 0.180 |
Why?
|
Testicular Diseases | 1 | 2000 | 73 | 0.180 |
Why?
|
Sarcoma, Alveolar Soft Part | 2 | 2017 | 43 | 0.170 |
Why?
|
Chromosomal Proteins, Non-Histone | 3 | 2015 | 727 | 0.170 |
Why?
|
Racemases and Epimerases | 4 | 2022 | 114 | 0.170 |
Why?
|
Receptors, Thrombopoietin | 1 | 2021 | 160 | 0.170 |
Why?
|
Sarcoma, Synovial | 2 | 2019 | 153 | 0.170 |
Why?
|
Inhibins | 4 | 2021 | 210 | 0.170 |
Why?
|
Neoplasm Metastasis | 6 | 2018 | 4915 | 0.170 |
Why?
|
Proportional Hazards Models | 6 | 2015 | 12463 | 0.170 |
Why?
|
Respiratory Mucosa | 1 | 2023 | 439 | 0.170 |
Why?
|
Indoles | 1 | 2008 | 1833 | 0.170 |
Why?
|
Benzoates | 1 | 2021 | 212 | 0.170 |
Why?
|
Polymerase Chain Reaction | 8 | 2017 | 6075 | 0.170 |
Why?
|
Muscle Neoplasms | 2 | 2011 | 130 | 0.170 |
Why?
|
Pelvic Floor | 2 | 2011 | 137 | 0.170 |
Why?
|
Hydrazines | 1 | 2021 | 224 | 0.170 |
Why?
|
Keratin-20 | 2 | 2012 | 31 | 0.170 |
Why?
|
RNA-Binding Proteins | 3 | 2017 | 1898 | 0.170 |
Why?
|
Thrombopoietin | 1 | 2021 | 226 | 0.160 |
Why?
|
Phosphoproteins | 3 | 2007 | 2448 | 0.160 |
Why?
|
Reproducibility of Results | 14 | 2023 | 20100 | 0.160 |
Why?
|
Cell Differentiation | 7 | 2021 | 11530 | 0.160 |
Why?
|
Cicatrix | 1 | 2005 | 798 | 0.160 |
Why?
|
Chelation Therapy | 2 | 2017 | 77 | 0.160 |
Why?
|
Abdomen | 1 | 2005 | 1128 | 0.160 |
Why?
|
Pelvic Neoplasms | 2 | 2011 | 247 | 0.160 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2022 | 455 | 0.160 |
Why?
|
Receptors, Estrogen | 5 | 2018 | 2209 | 0.160 |
Why?
|
Hepatocytes | 2 | 2017 | 1233 | 0.160 |
Why?
|
Loss of Heterozygosity | 3 | 2011 | 662 | 0.160 |
Why?
|
Myofibroblasts | 1 | 2020 | 223 | 0.160 |
Why?
|
GATA3 Transcription Factor | 2 | 2018 | 154 | 0.160 |
Why?
|
Time Factors | 9 | 2019 | 39969 | 0.160 |
Why?
|
Receptors, Steroid | 1 | 2019 | 156 | 0.160 |
Why?
|
Receptors, Thyroid Hormone | 1 | 2019 | 199 | 0.160 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2018 | 34 | 0.150 |
Why?
|
Mentors | 1 | 2024 | 661 | 0.150 |
Why?
|
Receptor, trkC | 1 | 2018 | 63 | 0.150 |
Why?
|
Pregnancy | 9 | 2020 | 29890 | 0.150 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2017 | 2297 | 0.150 |
Why?
|
Gene Dosage | 2 | 2020 | 1218 | 0.150 |
Why?
|
Iron | 2 | 2017 | 1793 | 0.150 |
Why?
|
Adenofibroma | 2 | 2008 | 25 | 0.150 |
Why?
|
Epoetin Alfa | 1 | 2018 | 78 | 0.150 |
Why?
|
Urothelium | 2 | 2012 | 269 | 0.150 |
Why?
|
Child | 17 | 2024 | 80158 | 0.150 |
Why?
|
Receptors, Fc | 1 | 2021 | 535 | 0.150 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 2 | 2015 | 92 | 0.150 |
Why?
|
Research Report | 1 | 2021 | 367 | 0.150 |
Why?
|
Rh Isoimmunization | 1 | 2017 | 23 | 0.150 |
Why?
|
DNA Polymerase II | 1 | 2018 | 104 | 0.150 |
Why?
|
Vulva | 1 | 2018 | 84 | 0.150 |
Why?
|
Salpingectomy | 1 | 2017 | 45 | 0.140 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 242 | 0.140 |
Why?
|
Pathology, Surgical | 2 | 2010 | 151 | 0.140 |
Why?
|
Electron Transport Complex I | 1 | 2018 | 153 | 0.140 |
Why?
|
North America | 4 | 2024 | 1276 | 0.140 |
Why?
|
DNA, Viral | 3 | 2015 | 2202 | 0.140 |
Why?
|
British Columbia | 2 | 2021 | 241 | 0.140 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2021 | 732 | 0.140 |
Why?
|
Adenoma, Oxyphilic | 1 | 2018 | 148 | 0.140 |
Why?
|
Europe | 6 | 2024 | 3420 | 0.140 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 4576 | 0.140 |
Why?
|
Melanoma | 3 | 2020 | 5709 | 0.130 |
Why?
|
Fibrosarcoma | 1 | 2018 | 309 | 0.130 |
Why?
|
Demography | 1 | 2021 | 1648 | 0.130 |
Why?
|
Keratin-7 | 2 | 2006 | 55 | 0.130 |
Why?
|
Oncogenes | 2 | 2012 | 1222 | 0.130 |
Why?
|
Cell Nucleolus | 2 | 2015 | 156 | 0.130 |
Why?
|
RNA-Binding Protein EWS | 1 | 2017 | 210 | 0.130 |
Why?
|
Glutathione | 1 | 2018 | 583 | 0.130 |
Why?
|
Calpain | 1 | 2016 | 146 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 12 | 2019 | 11742 | 0.130 |
Why?
|
TNF Receptor-Associated Factor 6 | 2 | 2013 | 61 | 0.130 |
Why?
|
Liver Neoplasms | 3 | 2017 | 4317 | 0.120 |
Why?
|
Hemoglobinopathies | 1 | 2016 | 99 | 0.120 |
Why?
|
Krukenberg Tumor | 1 | 2015 | 12 | 0.120 |
Why?
|
Hong Kong | 1 | 2015 | 166 | 0.120 |
Why?
|
History, 20th Century | 2 | 2014 | 2767 | 0.120 |
Why?
|
Gene Amplification | 3 | 2015 | 1089 | 0.120 |
Why?
|
Ploidies | 4 | 2019 | 285 | 0.120 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 583 | 0.120 |
Why?
|
Reactive Oxygen Species | 1 | 2023 | 2139 | 0.120 |
Why?
|
Apoptosis | 5 | 2016 | 9490 | 0.120 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2016 | 178 | 0.120 |
Why?
|
Pathology, Clinical | 1 | 2019 | 376 | 0.120 |
Why?
|
Neuroectodermal Tumors | 1 | 1994 | 22 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 8 | 2021 | 17904 | 0.120 |
Why?
|
Uterine Cervical Diseases | 1 | 1995 | 73 | 0.120 |
Why?
|
Lymphoma | 3 | 2020 | 1901 | 0.120 |
Why?
|
Annexin A2 | 1 | 2014 | 44 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2024 | 3639 | 0.120 |
Why?
|
Polycythemia | 1 | 2015 | 124 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2017 | 954 | 0.120 |
Why?
|
Fibroma | 2 | 2015 | 190 | 0.120 |
Why?
|
Ureteral Neoplasms | 1 | 1995 | 107 | 0.120 |
Why?
|
Muscle Proteins | 1 | 2020 | 1154 | 0.120 |
Why?
|
Paclitaxel | 5 | 2006 | 1732 | 0.120 |
Why?
|
Hyalin | 1 | 2014 | 34 | 0.120 |
Why?
|
Pregnancy Complications | 1 | 2008 | 2947 | 0.120 |
Why?
|
Endometritis | 1 | 2014 | 49 | 0.120 |
Why?
|
Brachytherapy | 1 | 2022 | 1223 | 0.110 |
Why?
|
Blood Transfusion | 3 | 2018 | 1301 | 0.110 |
Why?
|
Liver | 3 | 2017 | 7528 | 0.110 |
Why?
|
Monitoring, Immunologic | 1 | 2014 | 98 | 0.110 |
Why?
|
Urethra | 2 | 2010 | 405 | 0.110 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2015 | 311 | 0.110 |
Why?
|
Cesarean Section | 2 | 2017 | 1398 | 0.110 |
Why?
|
Infarction | 2 | 2013 | 248 | 0.110 |
Why?
|
Uveal Neoplasms | 1 | 2016 | 341 | 0.110 |
Why?
|
Desmin | 2 | 2004 | 99 | 0.110 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 709 | 0.110 |
Why?
|
Microsatellite Repeats | 2 | 2006 | 784 | 0.110 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2013 | 76 | 0.110 |
Why?
|
Lymphatic System | 1 | 2015 | 254 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 2 | 2022 | 2805 | 0.110 |
Why?
|
Mixed Tumor, Malignant | 1 | 2012 | 16 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 1 | 2021 | 3733 | 0.100 |
Why?
|
Receptor, erbB-2 | 3 | 2021 | 2557 | 0.100 |
Why?
|
Uterine Cervical Dysplasia | 2 | 2014 | 384 | 0.100 |
Why?
|
Mediator Complex | 1 | 2013 | 106 | 0.100 |
Why?
|
Chloride Channels | 1 | 2013 | 221 | 0.100 |
Why?
|
Desmosomes | 2 | 2010 | 72 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2021 | 5672 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2013 | 738 | 0.100 |
Why?
|
Cell Proliferation | 8 | 2020 | 10451 | 0.100 |
Why?
|
Thoracic Neoplasms | 1 | 1994 | 267 | 0.100 |
Why?
|
Antibodies, Monoclonal | 4 | 2014 | 9177 | 0.100 |
Why?
|
California | 1 | 2016 | 1430 | 0.100 |
Why?
|
International Cooperation | 3 | 2017 | 1422 | 0.100 |
Why?
|
Torsion Abnormality | 1 | 2012 | 91 | 0.100 |
Why?
|
Incidence | 3 | 2023 | 21355 | 0.100 |
Why?
|
Pancreatic Neoplasms | 2 | 2010 | 5368 | 0.100 |
Why?
|
NF-kappa B p52 Subunit | 1 | 2011 | 35 | 0.090 |
Why?
|
Diagnostic Imaging | 3 | 2011 | 3530 | 0.090 |
Why?
|
Survival Analysis | 8 | 2014 | 10090 | 0.090 |
Why?
|
Base Sequence | 4 | 2019 | 12441 | 0.090 |
Why?
|
Antigens, CD34 | 2 | 2004 | 658 | 0.090 |
Why?
|
Japan | 1 | 2015 | 1378 | 0.090 |
Why?
|
Pyrazoles | 1 | 2021 | 2009 | 0.090 |
Why?
|
Skin Neoplasms | 2 | 2020 | 5821 | 0.090 |
Why?
|
Immunoenzyme Techniques | 5 | 2010 | 1704 | 0.090 |
Why?
|
Liver Failure | 1 | 2012 | 250 | 0.090 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2011 | 287 | 0.090 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1092 | 0.090 |
Why?
|
Disease Progression | 4 | 2019 | 13510 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 6 | 2023 | 36426 | 0.090 |
Why?
|
Immunotherapy | 3 | 2019 | 4652 | 0.090 |
Why?
|
Transcription Factor RelA | 1 | 2011 | 254 | 0.090 |
Why?
|
Antigens, CD | 5 | 2016 | 4001 | 0.090 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2011 | 410 | 0.080 |
Why?
|
Specimen Handling | 2 | 2015 | 702 | 0.080 |
Why?
|
Carboplatin | 4 | 2006 | 794 | 0.080 |
Why?
|
Testis | 2 | 2004 | 794 | 0.080 |
Why?
|
Mucin-4 | 1 | 2009 | 33 | 0.080 |
Why?
|
Mitochondria | 2 | 2023 | 3624 | 0.080 |
Why?
|
DNA Methylation | 5 | 2021 | 4399 | 0.080 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2011 | 201 | 0.080 |
Why?
|
Sequence Analysis, RNA | 3 | 2022 | 2021 | 0.080 |
Why?
|
Cytoplasm | 5 | 2011 | 1510 | 0.080 |
Why?
|
Cell Line, Tumor | 10 | 2016 | 16990 | 0.080 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2010 | 117 | 0.080 |
Why?
|
Tamoxifen | 2 | 2008 | 965 | 0.080 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2013 | 899 | 0.080 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2012 | 1784 | 0.080 |
Why?
|
Gene Expression Profiling | 7 | 2019 | 9420 | 0.080 |
Why?
|
Pelvis | 2 | 2023 | 733 | 0.080 |
Why?
|
Cell Hypoxia | 1 | 2011 | 657 | 0.080 |
Why?
|
Thrombosis | 2 | 2021 | 2942 | 0.080 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2016 | 1252 | 0.080 |
Why?
|
World Health Organization | 4 | 2019 | 1322 | 0.080 |
Why?
|
Sensitivity and Specificity | 8 | 2017 | 14665 | 0.080 |
Why?
|
Homeodomain Proteins | 3 | 2013 | 2418 | 0.080 |
Why?
|
Chorionic Gonadotropin | 2 | 2004 | 457 | 0.080 |
Why?
|
Boronic Acids | 1 | 2012 | 915 | 0.070 |
Why?
|
PTEN Phosphohydrolase | 3 | 2013 | 1115 | 0.070 |
Why?
|
Genes, erbB-1 | 1 | 2008 | 162 | 0.070 |
Why?
|
Bartholin's Glands | 1 | 2007 | 5 | 0.070 |
Why?
|
Fibroblast Growth Factors | 1 | 2013 | 867 | 0.070 |
Why?
|
Urinary Bladder | 1 | 2014 | 1152 | 0.070 |
Why?
|
Antineoplastic Agents | 4 | 2023 | 13642 | 0.070 |
Why?
|
Cardiovascular System | 1 | 2015 | 834 | 0.070 |
Why?
|
Intraoperative Period | 1 | 2008 | 510 | 0.070 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 619 | 0.070 |
Why?
|
Mucins | 2 | 2022 | 568 | 0.070 |
Why?
|
Gene Deletion | 2 | 2024 | 2665 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2019 | 1896 | 0.070 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2007 | 247 | 0.070 |
Why?
|
Keratin-19 | 1 | 2006 | 33 | 0.070 |
Why?
|
Radiography, Interventional | 1 | 2014 | 1121 | 0.070 |
Why?
|
Genetic Testing | 2 | 2018 | 3537 | 0.070 |
Why?
|
Hemorrhage | 2 | 2021 | 3424 | 0.070 |
Why?
|
Wnt Proteins | 1 | 2011 | 718 | 0.070 |
Why?
|
Peritoneal Dialysis | 1 | 2008 | 159 | 0.070 |
Why?
|
Blotting, Western | 5 | 2015 | 5035 | 0.070 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2016 | 647 | 0.070 |
Why?
|
Parity | 1 | 2010 | 927 | 0.070 |
Why?
|
Clinical Protocols | 2 | 2010 | 1440 | 0.070 |
Why?
|
Lysosomes | 1 | 2012 | 924 | 0.070 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2007 | 310 | 0.070 |
Why?
|
History, 21st Century | 1 | 2013 | 1567 | 0.070 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1062 | 0.070 |
Why?
|
Gene Silencing | 2 | 2015 | 1509 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 6 | 2014 | 20568 | 0.070 |
Why?
|
Health Planning Guidelines | 1 | 2007 | 151 | 0.070 |
Why?
|
Pyrazines | 1 | 2012 | 1202 | 0.070 |
Why?
|
Immunoconjugates | 1 | 2014 | 953 | 0.070 |
Why?
|
Ultrasonography, Interventional | 1 | 2014 | 1496 | 0.070 |
Why?
|
Genes, p53 | 2 | 2024 | 712 | 0.070 |
Why?
|
Hematoporphyrin Photoradiation | 1 | 2005 | 17 | 0.070 |
Why?
|
Multivariate Analysis | 4 | 2020 | 12059 | 0.070 |
Why?
|
Infusions, Parenteral | 1 | 2006 | 397 | 0.060 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2007 | 418 | 0.060 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2006 | 82 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2012 | 1321 | 0.060 |
Why?
|
Maternal Welfare | 1 | 2006 | 112 | 0.060 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2008 | 284 | 0.060 |
Why?
|
United States | 8 | 2021 | 72340 | 0.060 |
Why?
|
Prospective Studies | 8 | 2019 | 54423 | 0.060 |
Why?
|
Carcinoma, Ductal | 1 | 2005 | 97 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2022 | 9032 | 0.060 |
Why?
|
alpha-Fetoproteins | 2 | 2004 | 223 | 0.060 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2004 | 46 | 0.060 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2007 | 180 | 0.060 |
Why?
|
Signal Transduction | 4 | 2013 | 23447 | 0.060 |
Why?
|
New York | 1 | 2007 | 874 | 0.060 |
Why?
|
Umbilical Cord | 1 | 2006 | 177 | 0.060 |
Why?
|
Cystadenocarcinoma | 1 | 2004 | 54 | 0.060 |
Why?
|
Calcium-Binding Proteins | 2 | 2016 | 1069 | 0.060 |
Why?
|
Appendiceal Neoplasms | 1 | 2006 | 155 | 0.060 |
Why?
|
Cystadenoma | 1 | 2004 | 79 | 0.060 |
Why?
|
Testicular Hormones | 1 | 2004 | 188 | 0.060 |
Why?
|
Radiation Injuries | 1 | 2012 | 1189 | 0.060 |
Why?
|
Autophagy | 1 | 2012 | 1327 | 0.060 |
Why?
|
Child, Preschool | 4 | 2022 | 42232 | 0.060 |
Why?
|
DNA Primers | 2 | 2011 | 2820 | 0.060 |
Why?
|
Brenner Tumor | 1 | 2003 | 9 | 0.060 |
Why?
|
Thrombophilia | 1 | 2007 | 305 | 0.060 |
Why?
|
Fibromatosis, Aggressive | 1 | 2005 | 126 | 0.060 |
Why?
|
S100 Proteins | 1 | 2004 | 218 | 0.060 |
Why?
|
Ferritins | 2 | 2017 | 598 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2014 | 3779 | 0.060 |
Why?
|
Calcium | 2 | 2016 | 5722 | 0.060 |
Why?
|
Mesonephros | 1 | 2003 | 42 | 0.060 |
Why?
|
Peritoneal Diseases | 1 | 2024 | 75 | 0.060 |
Why?
|
Placenta Diseases | 1 | 2006 | 199 | 0.060 |
Why?
|
Recurrence | 5 | 2024 | 8466 | 0.060 |
Why?
|
Intermediate Filament Proteins | 1 | 2004 | 262 | 0.060 |
Why?
|
Risk Factors | 8 | 2024 | 74213 | 0.050 |
Why?
|
Porphyrins | 1 | 2005 | 352 | 0.050 |
Why?
|
Serine Endopeptidases | 1 | 2008 | 1023 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2018 | 26202 | 0.050 |
Why?
|
Italy | 3 | 2017 | 842 | 0.050 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2007 | 699 | 0.050 |
Why?
|
Up-Regulation | 4 | 2013 | 4125 | 0.050 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2004 | 263 | 0.050 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 2022 | 35 | 0.050 |
Why?
|
Hyperplasia | 3 | 2022 | 1152 | 0.050 |
Why?
|
Adipogenesis | 1 | 2005 | 368 | 0.050 |
Why?
|
BRCA1 Protein | 1 | 2009 | 1158 | 0.050 |
Why?
|
Asia | 1 | 2024 | 619 | 0.050 |
Why?
|
Genes, ras | 1 | 2005 | 654 | 0.050 |
Why?
|
Rete Testis | 1 | 2022 | 10 | 0.050 |
Why?
|
Kidney | 2 | 2021 | 7048 | 0.050 |
Why?
|
Mice | 13 | 2023 | 81539 | 0.050 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2008 | 732 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2014 | 2226 | 0.050 |
Why?
|
Antigens, Neoplasm | 2 | 2000 | 1993 | 0.050 |
Why?
|
Mesoderm | 1 | 2005 | 674 | 0.050 |
Why?
|
MicroRNAs | 3 | 2013 | 3816 | 0.050 |
Why?
|
Inflammation | 2 | 2021 | 10774 | 0.050 |
Why?
|
CA-125 Antigen | 1 | 2005 | 281 | 0.050 |
Why?
|
Creatinine | 1 | 2008 | 1899 | 0.050 |
Why?
|
Thrombomodulin | 1 | 2003 | 105 | 0.050 |
Why?
|
Point Mutation | 3 | 2003 | 1595 | 0.050 |
Why?
|
Sirolimus | 1 | 2009 | 1533 | 0.050 |
Why?
|
Radiography, Abdominal | 1 | 2005 | 534 | 0.050 |
Why?
|
Acute Disease | 2 | 2011 | 7237 | 0.050 |
Why?
|
Genomics | 3 | 2024 | 5821 | 0.050 |
Why?
|
Mediastinum | 1 | 2003 | 266 | 0.050 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2008 | 1745 | 0.050 |
Why?
|
Down-Regulation | 3 | 2016 | 2919 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2013 | 1406 | 0.050 |
Why?
|
Hernia, Ventral | 1 | 2005 | 218 | 0.050 |
Why?
|
Animals | 17 | 2023 | 168475 | 0.050 |
Why?
|
Glutathione Synthase | 1 | 2001 | 3 | 0.050 |
Why?
|
Risk Assessment | 2 | 2022 | 23996 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2021 | 12 | 0.050 |
Why?
|
Medical Records | 1 | 2007 | 1408 | 0.050 |
Why?
|
Pelvic Exenteration | 1 | 2021 | 21 | 0.050 |
Why?
|
Promoter Regions, Genetic | 4 | 2018 | 5790 | 0.050 |
Why?
|
Myxosarcoma | 1 | 2000 | 11 | 0.050 |
Why?
|
Cell Adhesion Molecules | 2 | 2004 | 1601 | 0.050 |
Why?
|
Abdominal Pain | 2 | 2005 | 1071 | 0.050 |
Why?
|
ras Proteins | 1 | 2006 | 1054 | 0.050 |
Why?
|
Anemia, Hemolytic, Congenital | 1 | 2001 | 71 | 0.040 |
Why?
|
Fetal Diseases | 1 | 2006 | 913 | 0.040 |
Why?
|
Infant, Newborn, Diseases | 1 | 2006 | 589 | 0.040 |
Why?
|
Regression Analysis | 1 | 2010 | 6345 | 0.040 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2021 | 77 | 0.040 |
Why?
|
Ki-67 Antigen | 2 | 2013 | 629 | 0.040 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2004 | 621 | 0.040 |
Why?
|
Mediastinal Neoplasms | 1 | 2003 | 401 | 0.040 |
Why?
|
Condylomata Acuminata | 1 | 2000 | 75 | 0.040 |
Why?
|
Spain | 3 | 2013 | 487 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2003 | 1991 | 0.040 |
Why?
|
CDC2 Protein Kinase | 1 | 2021 | 213 | 0.040 |
Why?
|
Phosphorylation | 3 | 2020 | 8321 | 0.040 |
Why?
|
Databases, Factual | 3 | 2020 | 7968 | 0.040 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2006 | 617 | 0.040 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2008 | 1520 | 0.040 |
Why?
|
Mucin-1 | 1 | 2004 | 540 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 2023 | 730 | 0.040 |
Why?
|
RNA, Viral | 2 | 2018 | 2846 | 0.040 |
Why?
|
Neoplastic Stem Cells | 1 | 2007 | 1351 | 0.040 |
Why?
|
Ovarian Follicle | 1 | 2021 | 244 | 0.040 |
Why?
|
Carcinoid Tumor | 1 | 2001 | 224 | 0.040 |
Why?
|
Apyrase | 1 | 2002 | 373 | 0.040 |
Why?
|
Portugal | 1 | 2019 | 91 | 0.040 |
Why?
|
Sclerosis | 1 | 2020 | 210 | 0.040 |
Why?
|
Pedigree | 1 | 2007 | 4542 | 0.040 |
Why?
|
Fibrinolytic Agents | 1 | 2009 | 2084 | 0.040 |
Why?
|
Diagnostic Self Evaluation | 1 | 2021 | 224 | 0.040 |
Why?
|
Tubulin | 1 | 2003 | 693 | 0.040 |
Why?
|
Hepatitis C | 1 | 2009 | 1584 | 0.040 |
Why?
|
Actins | 2 | 2004 | 2050 | 0.040 |
Why?
|
Canada | 2 | 2017 | 2122 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2021 | 2872 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 1 | 2020 | 473 | 0.040 |
Why?
|
RNA, Neoplasm | 2 | 2012 | 750 | 0.040 |
Why?
|
Penile Neoplasms | 1 | 2000 | 161 | 0.040 |
Why?
|
Trans-Activators | 2 | 2005 | 2856 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 869 | 0.040 |
Why?
|
Taxoids | 1 | 2001 | 668 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2023 | 9542 | 0.040 |
Why?
|
Sternum | 1 | 1999 | 175 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10766 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 14033 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 851 | 0.040 |
Why?
|
Shoulder | 1 | 2019 | 300 | 0.040 |
Why?
|
Prostatic Neoplasms | 3 | 2006 | 11122 | 0.040 |
Why?
|
Infant | 2 | 2018 | 36193 | 0.040 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2017 | 47 | 0.040 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 1997 | 94 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2008 | 2091 | 0.040 |
Why?
|
Glycoproteins | 1 | 2004 | 2203 | 0.030 |
Why?
|
Ultrasonography | 2 | 2005 | 5971 | 0.030 |
Why?
|
Neoplasm Transplantation | 2 | 2013 | 2016 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2002 | 1134 | 0.030 |
Why?
|
New York City | 1 | 2019 | 731 | 0.030 |
Why?
|
Consensus | 2 | 2018 | 3124 | 0.030 |
Why?
|
Urethral Diseases | 1 | 1996 | 52 | 0.030 |
Why?
|
gamma Catenin | 1 | 2016 | 44 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2008 | 2576 | 0.030 |
Why?
|
Polymorphism, Single-Stranded Conformational | 3 | 2003 | 329 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4176 | 0.030 |
Why?
|
alpha Catenin | 1 | 2016 | 37 | 0.030 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 1997 | 210 | 0.030 |
Why?
|
Vagina | 1 | 2022 | 838 | 0.030 |
Why?
|
Epigenomics | 1 | 2022 | 943 | 0.030 |
Why?
|
Gender Identity | 1 | 2022 | 766 | 0.030 |
Why?
|
Desmoplakins | 1 | 2016 | 61 | 0.030 |
Why?
|
Gene Duplication | 1 | 2017 | 314 | 0.030 |
Why?
|
Image Enhancement | 1 | 2007 | 2884 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2018 | 638 | 0.030 |
Why?
|
Northern Ireland | 1 | 2015 | 37 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2016 | 147 | 0.030 |
Why?
|
Luteinization | 1 | 2015 | 10 | 0.030 |
Why?
|
Venous Thromboembolism | 1 | 2009 | 1866 | 0.030 |
Why?
|
Palliative Care | 1 | 2011 | 3598 | 0.030 |
Why?
|
Pathology, Molecular | 1 | 2019 | 328 | 0.030 |
Why?
|
Mice, SCID | 2 | 2013 | 2626 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2021 | 2677 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2012 | 18255 | 0.030 |
Why?
|
Cystectomy | 1 | 2000 | 634 | 0.030 |
Why?
|
Incidental Findings | 1 | 2020 | 697 | 0.030 |
Why?
|
Mice, Nude | 2 | 2014 | 3614 | 0.030 |
Why?
|
Microdissection | 1 | 2015 | 151 | 0.030 |
Why?
|
Peritoneum | 1 | 1996 | 225 | 0.030 |
Why?
|
Integrases | 2 | 2009 | 518 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2019 | 6228 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2008 | 3600 | 0.030 |
Why?
|
Hedgehog Proteins | 1 | 2020 | 768 | 0.030 |
Why?
|
Rhabdomyosarcoma | 1 | 1998 | 358 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2016 | 232 | 0.030 |
Why?
|
Transplantation Conditioning | 1 | 2001 | 1590 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2001 | 1263 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22174 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2002 | 1374 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2020 | 4740 | 0.030 |
Why?
|
Cohort Studies | 4 | 2021 | 41495 | 0.030 |
Why?
|
Fertility | 1 | 2019 | 771 | 0.030 |
Why?
|
Carcinoma, Medullary | 1 | 1995 | 115 | 0.030 |
Why?
|
Monitoring, Intraoperative | 1 | 2021 | 942 | 0.030 |
Why?
|
Massachusetts | 1 | 2007 | 8833 | 0.030 |
Why?
|
Poland | 1 | 2014 | 198 | 0.030 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 1995 | 283 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2009 | 4235 | 0.030 |
Why?
|
Staining and Labeling | 1 | 1998 | 1085 | 0.030 |
Why?
|
Sweden | 1 | 2017 | 1379 | 0.030 |
Why?
|
NF-kappa B | 2 | 2013 | 2490 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22173 | 0.030 |
Why?
|
Cystadenoma, Mucinous | 1 | 1993 | 62 | 0.030 |
Why?
|
Blood Glucose | 1 | 2008 | 6391 | 0.030 |
Why?
|
Adipose Tissue | 2 | 2021 | 3313 | 0.030 |
Why?
|
HIV Protease | 1 | 2013 | 97 | 0.030 |
Why?
|
Tumor Cells, Cultured | 3 | 2005 | 6131 | 0.030 |
Why?
|
Peptide Hydrolases | 1 | 2016 | 624 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2016 | 603 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3801 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 865 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2079 | 0.030 |
Why?
|
Periodicals as Topic | 1 | 2024 | 1463 | 0.030 |
Why?
|
Expert Testimony | 1 | 2015 | 364 | 0.030 |
Why?
|
Pharyngeal Neoplasms | 1 | 1992 | 113 | 0.030 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2012 | 46 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2012 | 1626 | 0.020 |
Why?
|
Prostatectomy | 1 | 2000 | 1824 | 0.020 |
Why?
|
Trophoblasts | 1 | 1993 | 224 | 0.020 |
Why?
|
Hemoglobins | 1 | 2018 | 1526 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 3701 | 0.020 |
Why?
|
Bone Marrow | 1 | 2002 | 2911 | 0.020 |
Why?
|
Lactates | 1 | 2012 | 405 | 0.020 |
Why?
|
RNA, Small Interfering | 2 | 2011 | 3430 | 0.020 |
Why?
|
Protein Phosphatase 2 | 1 | 2013 | 231 | 0.020 |
Why?
|
Erythrocytes | 1 | 2001 | 2413 | 0.020 |
Why?
|
Molecular Biology | 1 | 2015 | 576 | 0.020 |
Why?
|
Fluorescence | 1 | 2014 | 756 | 0.020 |
Why?
|
Cisplatin | 2 | 2010 | 1652 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2011 | 311 | 0.020 |
Why?
|
Phototherapy | 1 | 2014 | 368 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2321 | 0.020 |
Why?
|
International Normalized Ratio | 1 | 2012 | 382 | 0.020 |
Why?
|
Bilirubin | 1 | 2012 | 436 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2001 | 2775 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4948 | 0.020 |
Why?
|
Cytoplasmic Structures | 1 | 2010 | 21 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3878 | 0.020 |
Why?
|
Surgical Flaps | 1 | 1999 | 1671 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 8181 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4853 | 0.020 |
Why?
|
I-kappa B Kinase | 1 | 2011 | 250 | 0.020 |
Why?
|
Histocytochemistry | 1 | 1991 | 698 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2451 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 26129 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 1999 | 1529 | 0.020 |
Why?
|
Logistic Models | 2 | 2017 | 13255 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2012 | 629 | 0.020 |
Why?
|
Thyroid Neoplasms | 2 | 1995 | 2332 | 0.020 |
Why?
|
Paraffin Embedding | 1 | 2010 | 302 | 0.020 |
Why?
|
Patient Selection | 1 | 2001 | 4244 | 0.020 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1991 | 283 | 0.020 |
Why?
|
Luciferases | 1 | 2011 | 714 | 0.020 |
Why?
|
Intermediate Filaments | 1 | 2010 | 172 | 0.020 |
Why?
|
Microvessels | 1 | 2013 | 577 | 0.020 |
Why?
|
Case-Control Studies | 4 | 2009 | 22176 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2021 | 3688 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2008 | 3514 | 0.020 |
Why?
|
Registries | 2 | 2017 | 8225 | 0.020 |
Why?
|
Transplantation, Heterologous | 2 | 2007 | 2386 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5791 | 0.020 |
Why?
|
Contrast Media | 2 | 2012 | 5307 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2011 | 750 | 0.020 |
Why?
|
Ultrafiltration | 1 | 2008 | 49 | 0.020 |
Why?
|
Lentivirus | 1 | 2011 | 508 | 0.020 |
Why?
|
Comorbidity | 2 | 2016 | 10508 | 0.020 |
Why?
|
China | 1 | 2014 | 2374 | 0.020 |
Why?
|
Thyroid Gland | 1 | 1995 | 1170 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2010 | 695 | 0.020 |
Why?
|
Light | 1 | 2014 | 1353 | 0.020 |
Why?
|
Sertoli-Leydig Cell Tumor | 2 | 1998 | 19 | 0.020 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2014 | 946 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2832 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1745 | 0.020 |
Why?
|
SEER Program | 1 | 2012 | 1450 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2009 | 6534 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7593 | 0.020 |
Why?
|
Hepatocyte Growth Factor | 1 | 2008 | 271 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2012 | 1702 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2008 | 407 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2016 | 1899 | 0.020 |
Why?
|
Cyclosporine | 1 | 2009 | 778 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2004 | 5146 | 0.020 |
Why?
|
Stomach | 1 | 1991 | 696 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1612 | 0.020 |
Why?
|
Internet | 1 | 2019 | 3093 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2012 | 12794 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2005 | 21019 | 0.020 |
Why?
|
Cyclophosphamide | 2 | 2002 | 2220 | 0.020 |
Why?
|
Plasmids | 1 | 2011 | 2269 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2601 | 0.020 |
Why?
|
Genotype | 2 | 2010 | 12990 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2005 | 413 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3605 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2005 | 6938 | 0.020 |
Why?
|
Rats | 1 | 2021 | 23741 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5337 | 0.010 |
Why?
|
Area Under Curve | 1 | 2009 | 1638 | 0.010 |
Why?
|
Safety | 1 | 2009 | 1149 | 0.010 |
Why?
|
Microsatellite Instability | 1 | 2008 | 716 | 0.010 |
Why?
|
Papillomavirus Vaccines | 1 | 2010 | 496 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2735 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2012 | 2457 | 0.010 |
Why?
|
Endoscopy | 1 | 2014 | 1851 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12341 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3201 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 1999 | 3627 | 0.010 |
Why?
|
Biological Transport | 1 | 2008 | 2091 | 0.010 |
Why?
|
Longitudinal Studies | 2 | 2011 | 14608 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2007 | 1827 | 0.010 |
Why?
|
Transfection | 1 | 2011 | 5774 | 0.010 |
Why?
|
Histocytological Preparation Techniques | 1 | 2003 | 33 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2003 | 427 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2015 | 3029 | 0.010 |
Why?
|
Swine | 1 | 2012 | 5915 | 0.010 |
Why?
|
Bone Marrow Purging | 1 | 2002 | 108 | 0.010 |
Why?
|
Thiotepa | 1 | 2001 | 66 | 0.010 |
Why?
|
Hepacivirus | 1 | 2009 | 1336 | 0.010 |
Why?
|
Leukapheresis | 1 | 2002 | 134 | 0.010 |
Why?
|
CHO Cells | 1 | 2004 | 1387 | 0.010 |
Why?
|
Genes, bcl-2 | 1 | 2002 | 119 | 0.010 |
Why?
|
Cell Separation | 1 | 2007 | 1720 | 0.010 |
Why?
|
Life Tables | 1 | 2002 | 364 | 0.010 |
Why?
|
Epithelium | 2 | 1996 | 1603 | 0.010 |
Why?
|
Mitoxantrone | 1 | 2001 | 148 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2010 | 1712 | 0.010 |
Why?
|
Drug Synergism | 1 | 2005 | 1757 | 0.010 |
Why?
|
Primary Prevention | 1 | 2009 | 1186 | 0.010 |
Why?
|
Photosensitizing Agents | 1 | 2005 | 623 | 0.010 |
Why?
|
Cricetinae | 1 | 2004 | 2423 | 0.010 |
Why?
|
Malondialdehyde | 1 | 2001 | 112 | 0.010 |
Why?
|
Trisomy | 1 | 2002 | 260 | 0.010 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 2001 | 65 | 0.010 |
Why?
|
ROC Curve | 1 | 2009 | 3578 | 0.010 |
Why?
|
Proteomics | 1 | 2014 | 3848 | 0.010 |
Why?
|
Age Factors | 3 | 2010 | 18399 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2000 | 66 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5872 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2009 | 1881 | 0.010 |
Why?
|
Carcinoma, Verrucous | 1 | 2000 | 27 | 0.010 |
Why?
|
Melphalan | 1 | 2001 | 420 | 0.010 |
Why?
|
DNA | 1 | 1994 | 7213 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2005 | 2927 | 0.010 |
Why?
|
DNA Damage | 1 | 2010 | 2449 | 0.010 |
Why?
|
Chromogranins | 1 | 2000 | 161 | 0.010 |
Why?
|
Vincristine | 1 | 2002 | 1036 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2004 | 2115 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15601 | 0.010 |
Why?
|
Mediastinitis | 1 | 1999 | 49 | 0.010 |
Why?
|
Probability | 1 | 2004 | 2477 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2005 | 1342 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3449 | 0.010 |
Why?
|
Back Pain | 1 | 2003 | 545 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 3359 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 2850 | 0.010 |
Why?
|
X Chromosome | 1 | 2002 | 816 | 0.010 |
Why?
|
Adipocytes | 1 | 2005 | 1194 | 0.010 |
Why?
|
Epididymis | 1 | 2000 | 228 | 0.010 |
Why?
|
Cytokines | 1 | 2013 | 7396 | 0.010 |
Why?
|
Mucous Membrane | 1 | 2001 | 659 | 0.010 |
Why?
|
Favism | 1 | 1997 | 3 | 0.010 |
Why?
|
Leg | 1 | 2003 | 1088 | 0.010 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2001 | 617 | 0.010 |
Why?
|
Africa, Northern | 1 | 1997 | 86 | 0.010 |
Why?
|
Prednisone | 1 | 2002 | 1563 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2002 | 1008 | 0.010 |
Why?
|
Exons | 1 | 2003 | 2391 | 0.010 |
Why?
|
Neutropenia | 1 | 2001 | 885 | 0.010 |
Why?
|
Debridement | 1 | 1999 | 493 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2001 | 858 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2000 | 1606 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2007 | 2828 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2010 | 5305 | 0.010 |
Why?
|
Nucleolus Organizer Region | 1 | 1995 | 25 | 0.010 |
Why?
|
Silver Staining | 1 | 1995 | 62 | 0.010 |
Why?
|
Doxorubicin | 1 | 2002 | 2224 | 0.010 |
Why?
|
Microvilli | 1 | 1995 | 234 | 0.010 |
Why?
|
Luteal Cells | 1 | 1994 | 19 | 0.010 |
Why?
|
Mass Screening | 1 | 2010 | 5429 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2004 | 2469 | 0.010 |
Why?
|
Infection Control | 1 | 2001 | 982 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14417 | 0.010 |
Why?
|
Neurosecretory Systems | 1 | 1995 | 223 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 1997 | 732 | 0.010 |
Why?
|
Fever | 1 | 2001 | 1618 | 0.010 |
Why?
|
Flow Cytometry | 2 | 1994 | 5870 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2003 | 1879 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 17635 | 0.010 |
Why?
|
Plasma Cells | 1 | 1996 | 599 | 0.010 |
Why?
|
Chronic Disease | 1 | 2008 | 9319 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1995 | 2561 | 0.010 |
Why?
|
Oropharynx | 1 | 1992 | 138 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2001 | 6312 | 0.010 |
Why?
|
Radiotherapy | 1 | 1998 | 1498 | 0.010 |
Why?
|
Risk | 1 | 2001 | 9610 | 0.010 |
Why?
|
Suicide, Attempted | 1 | 1978 | 1402 | 0.000 |
Why?
|
Peptides | 1 | 2000 | 4358 | 0.000 |
Why?
|
Pain | 1 | 2003 | 5073 | 0.000 |
Why?
|
Membrane Proteins | 1 | 2004 | 7859 | 0.000 |
Why?
|
Biopsy, Needle | 1 | 1992 | 1626 | 0.000 |
Why?
|
Polymorphism, Genetic | 1 | 1997 | 4243 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2004 | 15843 | 0.000 |
Why?
|
Postoperative Care | 1 | 1992 | 1468 | 0.000 |
Why?
|
Proteins | 1 | 2000 | 6032 | 0.000 |
Why?
|
Radiotherapy Dosage | 1 | 1992 | 2898 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2001 | 7406 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1994 | 9001 | 0.000 |
Why?
|
Marriage | 1 | 1978 | 351 | 0.000 |
Why?
|
Educational Status | 1 | 1978 | 2522 | 0.000 |
Why?
|
Family | 1 | 1978 | 3195 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 1978 | 7828 | 0.000 |
Why?
|
Sex Factors | 1 | 1978 | 10554 | 0.000 |
Why?
|
Mental Disorders | 1 | 1978 | 6845 | 0.000 |
Why?
|